InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Twist Bioscience Corp

TWST Clue Score57
United States Fiscal year ends September CIK 0001581280 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

42
Insider
Date
Role
Action
Shares
Price
Amount
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
45
$207.46
$9.34K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
146
$206.84
$30.20K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
297
$205.78
$61.12K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
290
$204.80
$59.39K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
432
$203.61
$87.96K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
1,017
$202.32
$205.76K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
481
$201.26
$96.80K
Emily M. Leproust
5 Oct 2026
Chief Executive Officer
Sold on a plan
1,840
$200.44
$368.81K
Emily M. Leproust
2 Oct 2026
Chief Executive Officer
Sold on a plan
45,736
$188.88
$8.64M
Emily M. Leproust
1 Oct 2026
Chief Executive Officer
Sold on a plan
655
$200.00
$131.00K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
83
$184.60
$15.32K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
501
$183.76
$92.07K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
16
$182.50
$2.92K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
21
$181.45
$3.81K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
515
$180.39
$92.90K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
143
$179.93
$25.73K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
330
$178.67
$58.96K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
164
$177.17
$29.06K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
945
$176.39
$166.69K
Emily M. Leproust
24 Sep 2026
Chief Executive Officer
Sold on a plan
2,485
$175.23
$435.45K
Emily M. Leproust
25 Aug 2026
Chief Executive Officer
Sold on a plan
1,093
$154.45
$168.81K
Emily M. Leproust
25 Aug 2026
Chief Executive Officer
Sold on a plan
9,181
$153.93
$1.41M
Emily M. Leproust
25 Aug 2026
Chief Executive Officer
Sold on a plan
6,412
$152.75
$979.43K
Emily M. Leproust
25 Aug 2026
Chief Executive Officer
Sold on a plan
12,236
$151.36
$1.85M
Emily M. Leproust
25 Aug 2026
Chief Executive Officer
Sold on a plan
12,648
$150.56
$1.90M
Dennis Cho
19 Aug 2026
See Remarks
Sold on a plan
14,205
$129.75
$1.84M
Dennis Cho
5 Aug 2026
See Remarks
Sold on a plan
14,205
$109.75
$1.56M
Emily M. Leproust
25 Jun 2026
Chief Executive Officer
Sold on a plan
18,880
$95.00
$1.79M
Dennis Cho
24 Jun 2026
See Remarks
Sold on a plan
14,205
$89.75
$1.27M
Adam Laponis
29 May 2026
Chief Financial Officer
Sold on a plan
4,000
$70.00
$280.00K
Dennis Cho
29 May 2026
See Remarks
Sold on a plan
14,205
$69.75
$990.80K
Melissa A. Starovasnik
28 May 2026
Director
Sold on a plan
2,500
$68.00
$170.00K
Melissa A. Starovasnik
26 May 2026
Director
Sold on a plan
500
$61.04
$30.52K
Melissa A. Starovasnik
27 Apr 2026
Director
Sold on a plan
500
$61.83
$30.92K
Adam Laponis
17 Apr 2026
Chief Financial Officer
Sold on a plan
4,000
$60.00
$240.00K
Adam Laponis
14 Apr 2026
Chief Financial Officer
Sold on a plan
3,000
$55.00
$165.00K
Melissa A. Starovasnik
1 Apr 2026
Director
Sold on a plan
1,000
$51.00
$51.00K
Adam Laponis
12 Feb 2026
Chief Financial Officer
Sold on a plan
7,000
$50.00
$350.00K
Dennis Cho
11 Feb 2026
See Remarks
Sold on a plan
5,000
$49.93
$249.65K
Adam Laponis
13 Jan 2026
Chief Financial Officer
Sold on a plan
3,000
$40.00
$120.00K
Adam Laponis
9 Oct 2025
Chief Financial Officer
Sold on a plan
2,517
$32.92
$82.86K
Adam Laponis
8 Oct 2025
Chief Financial Officer
Sold on a plan
3,000
$31.15
$93.45K
Showing 250 of 1,064 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 961
Amendments (4/A) skipped 22
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 43
Sales straight out of an exercise 328
Sales at will 662
Transactions with no price 0
Shares from compensation/vesting 20,302,686
Sales filed before the plan box existed 380
History held since 1 Nov 2018